Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Mack Gene | Aug 9, 2024 | Buy | 14,400 | $1.01 | $15,000 |
| Islam Khalid | Aug 9, 2024 | Buy | 50,000 | $0.9988 | $50,000 |
| RICHMAN ERIC I | Jul 1, 2024 | Buy | 12,000 | $1.21 | $15,000 |
| RICHMAN ERIC I | Jul 1, 2024 | Buy | 5,000 | $1.23 | $6,200 |
| Riley Jeffrey Scott | Mar 28, 2024 | Buy | 30,000 | $3.859 | $120,000 |
| Alder Matthias | Dec 21, 2023 | Sell | 206 | $2.46 | $510 |
| Alder Matthias | Dec 7, 2023 | Sell | 1,820 | $2.5 | $4,600 |
What's the latest insider transaction for Gain Therapeutics?
The most recent insider transaction for Gain Therapeutics was conducted by Mack Gene, who sold 14,400 shares on August 9, 2024 at a price of $1.01 per share.
Which insider bought the most GANX stock over the last two years?
Riley Jeffrey Scott has bought the most GANX stock in the last 2 years, with a total value of $120,000.
Which insider has sold the most GANX stock over the last two years?
Alder Matthias has sold the most GANX stock in the last 2 years, with a total value of $5,100.
What is the total value of insider transactions for Gain Therapeutics (GANX) in the last 2 years?
According to our estimates, the total value of insider transactions for Gain Therapeutics in the last 2 years is positive, amounting to $200,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Gain Therapeutics' market confidence?
Over the last 2 years, insider transactions for Gain Therapeutics have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
